Guide For Authors

1. Asthma Allergy Immunology is the periodical journal ofthe Turkish National Society of Allergy and Clinical Immunology, three times a year.

2. The aim of the journal; is to present advances in the field of allergic diseases and clinical immunology to the readers. In accordance with this goal, manuscripts in the format of original research, review, case report, articles about clinical and practical applications and editorials, short report and letters to the editor about allergic diseases and clinical immunology are published in the journal.

3. The official languages ofthe journal are Turkish and English. Turkish manusc-ripts should complywith the Dictionaryand SpellingGuide of the Turkish Linguistic Society( Anatomic terminologyshould be based on Latin nomenclature. Terms in dailymedical language should be written as read and accordingto Turkish spellingrules. Terms written in English or another foreign language should be indicated within quotation marks.

4. All manuscripts submitted for publication should comply with “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” pro-duced and updated by the International Committee ofMedical Journals Editors (

5. Compliance with the Declaration ofHelsinki Principles ( acceptedas the policy of Asthma Allergy Immunology. Therefore, all manuscripts concerning human subjects must contain a statement in the “Materials andMethods” section, indicating that the study was approved by the Institutional Review Board. All study subjects should be informed and written consent should be obtainedandthis should be declaredin the “Materials and Methods”section. All manuscripts dealing withanimalsubjects must contain a statement indicating that the study was performed according to “The Guide for the Care and Use ofLaboratory Animals” ( with the approval ofthe Institutional Review Board, in the “Materials and Methods” section. The Editor may ask for a copy of the approval document.

6. The editor has the right to format or reject the manuscripts which do not follow therules or send them back to the author for correction. Authors who wish to withdraw their manuscripts need to state this to the editör in written form. Asthma Allergy Immunology employs a plagiarism detection system. Authors accept that their manuscript may be screened for pilagiarism againts previously published works.

7. Submitted papers are reviewed by the, the editor, the associated editors, and at least two reviewers. The editor and associated editors may decide to send the manuscript to a third reviewer. The editor and associated edi-tors is the complete authorityregardingreviewer selection. The reviewers may be selected from the International Advisory Board or independent national or international reviewers may be selected when required for the topic of the manuscript.

8. The dates of received and accepted ofthe manuscript are stated in the end ofthe manuscript when published in the journal.

9. The manuscripts should be submittedvia online manuscript evaluation system (

10. The manuscript text should be written in Times New Roman font, 10 point-type, double-spaced with 2 cm margins on the left and right sides. The article should be prepared with IBM compatible computer programs (Microsoft Windows, Word 98). The pages should be numbered starting with the title page. Page numbers should appear at the bottom right corner of every page. The main text file should not contain anyinformation regarding author names and affiliations.

11. A cover letter (author agreement form), signed bythe authors in the same order ofauthors as stated in the article, declaring that the manuscript has not been published or is not currently submitted to another journal and that the manuscript is approved by all the authors should be e-mailed to [email protected] after being scanned or should be faxed to +90 312 219 66 57 simultaneous with the online upload of the manuscript. The signed cover letter should include scientific contributions and responsibilities of each author, and whether there is a conflict of interest regardingmanuscript. This form is available on Original signed document shall

be mailed to “Prof. Dr. Fazıl orhan, Astım Allerji İmmünoloji Editörü, Karadeniz Teknik Üniversitesi Tıp Fakültesi, Çocuk İmmünoloji ve Allerji Bilim Dalı, 61100 Trabzon-Türkiye” via post or cargo.

12. Allthe entities that provide contribution to the technicalcontent, data collection and analysis, writing, revision etc. ofthe manuscript and yet do not meet the criteria to be an author should be mentionedin the acknowledgement part. Ifthe contribution ofthe sponsor is only in the form of financial support, this should be stated in the “Acknowledgement” section. If the sponsor has participated in the methods, statistical analysis or manuscript preparation, this contribution shouldalso be stated in the “Materials and Methods” section. If there is no conflict ofinterest it should also be stated.

13. The manuscript which has been presented previouslyas an abstract in any congress or symposium may be mentioned on condition with the statement of the date and the place of the meeting.

14. Abbreviations should be internationally accepted and should be defined accordinglyin the text in parenthesis when first mentioned and used in the text. The abbreviated form should be used all throughout the article. “How To Write and Publish Scientific Articles” ( can be referred for international abbreviations.

15. Title page ofthe manuscript should include the Turkish and English title of the article, Turkish and English running title not exceeding 40 characters including spaces as well as the full names, surnames and academic degrees of the authors. The department, division and institution ofthe authors should be indicated. Title page should also include address, e-mail, phone and fax number of the corresponding author. Authors should indicate whether the research has been presented previously in a congress or symposia.

16. All manuscripts except “Letters to the Editor” should include Turkish and English abstracts. Abbreviations should be avoided in abstracts. References, figures, tables and citations should not be used.

17. There should be two to five keywords complying with the Index Medicus medical Subject Headings (MeSH). Refer to for keywords.


ResearchArticles shouldinclude; Turkishtitle, Turkishstructuredabstract (limitedto 300 words structured as Objective, Materials andMethods, Results andConclusion), Turkish key words and English title, English structured abstract (limitedto 300 words structured as Objective, Materials and Methods, Results andConclusion), English key words. The other sections of the manuscript should include Introduction, Materials and Methods, Results, Discussion, Acknowledgement (if required) and References. All sections of the manuscripts should start on a new page. Research articles are not referred to exceed 5000 words and 40 references.


Manuscripts in the form of“Reviews” are accepted when “invited” since 2009. In case of wishing to write a review about a current topic without being “invited”, the editor and the associate editors should be contacted before the manuscript is submitted. Review Articles should include; Turkish title, Turkish abstract, Turkish keywords and English title, English abstract and English keywords. The abstract should be preparedas one paragraph in “Review” type articles and limited to 300 words. Structured abstract is not required. Review articles are not referred to exceed 8000 words and 40 references.


Case reports should include Turkish title, Turkish abstract, Turkish key words, English title, English abstract, English keywords, Introduction, Case presentation, Discussion and References. Introduction and Discussion sections ofthe Case reports should be short and concise and the abstract should be preparedas one paragraph. Structured abstract is not required. Case reports should not exceed 1500 words and the number of references should not exceed 20.


Short reports should include research results in the related field in a short and concise form. Short reports should be limited to 1500 words. Short reports should include Turkish and English title, Turkish and English abstract in one paragraph and 2-5 key words in Turkish and English. Number of tables should be limited to 2 and that of the figure/graphic/picture should be limited to 1. Structured abstract is not required. Number of references should be limited to 10.


Letters to the Editor should be short and concise limited to 1000 words and 10 references, since they are prepared to criticize or contribute to the articles previously published in the journal.


Tables, figures, graphics and pictures should be numbered with Arabic numbers in order of appearence in the text. Localization oftables, figures, graphics andpictures should be indicated. Each table should be prepared with double spacing on a separate page. Tables should have a brief title. Authors should place explanatory matter in footnotes not in the heading. Explanations should be made for all nonstandard abbreviations in footnotes. The following symbols should be used for abbreviations in sequence: *,†,‡,§,||,¶,**,††,‡‡. Each table should be citedin text.

Figures should be either professionally drawn or photographed, and these items should be submitted as photographic-quality digital images. Figures should be submitted in a format that will produce high-quality image (for example, JPEG or GIF). Authors should control the images of such files on a computer screen before submitting them to be sure they meet their own quality standards.

X-ray films, scans and other diagnostic images, as well as pictures of pathology specimens should be submitted as sharp, glossy, black-and-white or color photographic images. Letters, numbers, and symbols on figures should be clear and consistent throughout, and large enough to remain legible when the figure is reduced for publication. Figures should be made as self-explanatoryas possible. For recognizable photographs ofpatients, signed releases ofthe patient or of his/her legal representative should be submitted; otherwise, patient names or eyes must be blocked out to prevent identification.

Legends for figures, graphics and pictures should be typed starting on a separate page, double spaced, indicating the corresponding illustrations with numbers. When symbols, arrows, numbers or letters are used to identify parts of illustrations, define each one clearly under the illustration.

If quoted parts, tables, figures, graphics, pictures etc exist in the manuscript, the authors should obtain written permission from the author and copyright holder and indicate this.


Data and manuscript not published yet should not be included among the references. These should be stated in the main text as “author(s), unpublished data, year”.

Reference numbers should be indicated at the end of the sentencesin the text as superscripts and references should be numbered consecutively in the order theyare mentionedin the text. Journal names should be abbreviated as listed in “Index Medicus” or in “ULAKBIM/Turkish Medical Index”. References should be typed in consistence with the following examples. Native references should be used as much as possible.

Ifthe reference is a journal;

Author(s)’ surname and initial(s) of the first name (all authors if the number of authors are 6 or less, first 6 authors if the number of authors of an article is more than 6 followed by “ve ark.” in Turkish references and “et al.” İn international references). Title of the article, title of the manuscript abbreviated accordingto Index Medicus ( Year;Volume:First and last page number.

Example: Benson M, Reinholdt J, Cardell LO. Allergen-reactive antibodies are found in nasal fluids from patients with birch polen-induced intermittent allergic rhinitis, but not in healthy controls. Allergy 2003;58:386-93.

Ifthe reference is a journal supplement;

Author(s)’ surname and initial(s) ofthe first name. Title ofthe article. Title of the manuscript abbreviated according to Index Medicus (  fcgi?db=nlmcatalog). Year;Volume (Suppl. Supplement number):First and last page number.

Example: Queen F. Risk assessment of nickel carcinogenicity and occupational lung cancer. Envirol Health Perspect 1994;102 (Suppl. 1):S2755-S2782.

If the reference is a book;

Author(s)’ surname and initial(s)ofthe first name. Title ofthe book. Editi-on number. Cityofpublication; Publisher, Year ofPublication.

Example: Ringsven MK, Bond N. Gerontology and leadership skills for nurses. 2nd ed. Albany, NY: Delmar, 1996.

If the reference is a book chapter;

Surname and initial(s) of the first name of the author(s) of the chapter. Title of the chapter. In: Surname and initial(s) of the first name(s) of the editor(s)(ed) or (eds). Title of the book. Edition number. City of publication: Publisher, Year of publication: First and last page numbers of the chapter.

Example: Phillips SJ, Whistant JP. Hypertension andstroke. In: LaraghJH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. 2 nd ed. New York: Raven P,1995:466-78.

Ifthe reference is an article presented in a meeting;

Author(s)’ surname and initial(s) of the first name (all authors if the number of authors are 6 or less, first 6 authors if the number of authors of an article is more than 6 followed by “ve ark.” in Turkish references and “et al.” in international references).Title of the article, If applicable In:Surname and initial(s) ofthe first name(s) ofthe editor(s) (ed) or (eds). Title ofthe book. Title ofthe meeting; Date; City ofthe meeting; Country. Publisher; Year.Page numbers.

Example: Bengtsson S, Solheim BG. Enforcement of data protection, privacyand security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Reinhoff O (eds). MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland. North-Holland; 1992. p. 1561-5.

If the reference is an online journal;

Author(s)’ surname and initial(s) of the first name (all authors if the number ofauthors are 6 or less, first 6 authors if the number ofauthors ofan article is more than 6 followed by “ve ark.” in Turkish references and “et al.” in international references). Title ofthe article, title ofthe manuscript abbreviatedaccording to Index Medicus Year; Volume (Number). Available from:URL address. Accessed date:day.month.year.

Example: Morse SS. Factors in the emergence ofinfectious disease. Emerg Infect Dis 1995;1(1). Available from: URL:http://www/cdc/gov/ncidoc/EID/eid.htm. Accessed date:25.12.1999.

If the reference is a website;

Name of theweb site. Access date. Available from: address of theweb site.

World Health Organization (WHO). Access date: 9 July 2008. Available from:

If the reference is a thesis;

Author’s surname and initial of the first name. Title of the thesis (thesis). City; Name of the university(if it is a university); Year.

Example: Erkan ML. Investigation ofclinical and laboratory features of asthma patients with aspirin sensitivity (Thesis). Ankara: Hacettepe University; 1989.

25. Scientific and legal responsibility of the published articles belongs to the authors. Authors are responsible for the ideas and comments in the manuscript as well as the accuracy of the references. Turkish National Society of Allergy and Clinical Immunology, the Editor, the Associated Editors or the publisher do not accept any responsibility for the published articles. The copyright ofthe articles accepted for publication belongto the Turkish National Society ofAllergy and Clinical Immunology. “Copyright Transfer Form” that will be sent to the e-mail ofthe corresponding author after acceptance of the manuscript for publication should be signed by all authors and sent via e-mail to [email protected], or faxed to +90 332 223 61 81. This form is available on Original signed document shall be mailed to “Prof. Dr. Fazıl Orhan, Astım Allerji İmmünoloji Editörü, Karadeniz Teknik Üniversitesi Tıp Fakültesi, Çocuk İmmünoloji ve Allerji Hastalıkları Bilim Dalı, Trabzon-Türkiye” via post or cargo.

26. There is no royalty payment to the authors.

27. Citation

Asthma Allergy Immunol

28. Publication Rights

Publication rights of Instructions to Authors of Asthma Allergy Immunology belong to the Buluş Yayinevi and the Turkish National Society of Allergy and Clinical Immunology and all rights are reserved).

Authors who submit their studies to Asthma Allergy Immunology should acknowledge that they have to transfer the copyright of their studies to the Turkish National Society of Allergy and Clinical Immunology. The editorial board of the journal is authorized to publish the study. Nonetheless, the following rights are reserved:

  • Patent rights,
  • All unregistered rights apart from copyright,
  • Duplication rights on condition that the study is not sold,
  • The right to use the whole or parts of the study in the author's own books or other academic studies on condition that reference is given,
  • The right to publish the study on personal websites or open archive of their university on condition that the copyright details are provided.

Manuscripts, figures and tables published in Asthma Allergy Immunology may not be reproduced in part or completely, archived in a retrieval system or used for advertising purposes without a written permission from the Turkish National Society ofAllergy and Clinical Immunology. Quotations may be used in scientific articles as long as they are referred. Related company is responsible for the content of the advertisements published in the journal. The Asthma Allergy Immunology is available online free of charge and contents of the journal can be accessed from the journal’s website at:


Fazıl Orhan, MD, Professor (Editor in Chief)

Address: Karadeniz Technical University Faculty of Medicine Division of Pediatric Immunology and Allergy Diseases

61100 Trabzon-Turkey

Phone: 0462 377 53 82

Fax : 0312 219 66 57

E-mail : [email protected]

Tüm hakları saklıdır. © 2016 AAI